Health - Eyesight latest news

Bausch & Lomb announced that it has received approval from the Food and Drug Administration (FDA) to market the Crystalens HDT in the United States. Crystalens accommodating intraocular lens (IOL) was first approved by the FDA in November 2003. The Crystalens HD is the fourth generation of the only FDA approved accommodating lens. The surface of the Crystalens HD has been shaped to enhance the depth of focus with a proprietary optical modification.

NanoViricides, Inc. (OTC BB: NNVC.OB) (the "Company"), said that an internationally renowned Japanese ophthalmologist and corneal researcher, Kazuo Tsubota, MD, PhD, has agreed to perform confirmatory animal efficacy studies of the nanoviricide anti-EKC drug candidate, EKC-CideT, against EKC (epidemic kerato-conjunctivitis) in Japan. Dr. Tsubota is currently Professor and Chairman of the Department of Ophthalmology at Keio University School of medicine in Tokyo, Japan.

Ophthalmologists (Eye M.D.s) continue to develop treatments to help the more than three million Americans with glaucoma. The July issue of Ophthalmology includes a large, national study of outcomes of incisional surgeries, used to reduce pressure inside the eye, in Medicare patients. Also covered is research that may brighten the outlook for patients with end-stage glaucoma.

Title: Glaucoma Treatment Can Prevent BlindnessCategory: health newscreated: 7/3/2008 2:00:00 amlast Editorial review: 7/3/2008

Title: Nearly Half of Eye Injuries Occur at HomeCategory: health newscreated: 7/3/2008Last Editorial review: 7/3/2008